Wstęp
Ta strona zawiera kompleksową analizę znanej historii wykorzystywania informacji poufnych w firmie Timothy P Clackson. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Dokonywanie transakcji w ich firmach w oparciu o określone, niepubliczne informacje jest nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4. Pomimo tych ograniczeń badania akademickie sugerują, że insiderzy – ogólnie rzecz biorąc – mają tendencję do osiągania lepszych wyników na rynku w swoich własnych firmach.
Średnia rentowność handlu
Średnia rentowność handlu to średni zwrot ze wszystkich zakupów na otwartym rynku dokonanych przez osobę mającą dostęp do informacji poufnych w ciągu ostatnich trzech lat. Aby to obliczyć, badamy każdy nieplanowany zakup na otwartym rynku dokonany przez insidera, z wyłączeniem wszystkich transakcji oznaczonych jako część planu handlowego 10b5-1. Następnie obliczamy średnią wydajność tych transakcji w ciągu 3, 6 i 12 miesięcy, uśredniając każdy z tych okresów, aby wygenerować ostateczny wskaźnik wydajności dla każdej transakcji. Na koniec uśredniamy wszystkie wskaźniki wydajności, aby obliczyć wskaźnik wydajności dla insidera. Na tej liście znajdują się wyłącznie insiderzy, którzy dokonali co najmniej trzech transakcji w ciągu ostatnich dwóch lat.
Jeśli rentowność handlu insiderów jest oznaczona notką„nie dotyczy”, oznacza to, że insider albo nie dokonał żadnych zakupów na otwartym rynku w ciągu ostatnich trzech lat, albo transakcje, których dokonał, są zbyt nowe, aby obliczyć wiarygodny wskaźnik wydajności.
Częstotliwość aktualizacji: codziennie
Spółki posiadające zgłoszone stanowiska osób mających dostęp do poufnych informacji
Z dokumentów SEC wynika, że Timothy P Clackson zgłosił udziały lub transakcje w następujących spółkach:
| Papier wartościowy | Nazwa | Najnowsze raporty dotyczące udziałów |
|---|---|---|
| US:ELEV / Elevation Oncology, Inc. | Director | 0 |
| US: / THESEUS PHARMACEUTICALS INC | President and CEO, Director | 351 030 |
| US:FMTX / Forma Therapeutics Holdings Inc | Director | 0 |
| US:XLO / Xilio Therapeutics, Inc. | 10% Owner | 20 068 |
| US:849CVR014 / CVR F STAR | Director | 50 486 |
| US:ARIA / ARIAD Pharmaceuticals, Inc. | President, R&D, CSO | 0 |
Jak interpretować wykresy
Poniższe wykresy przedstawiają notowania akcji papierów wartościowych po każdej niezaplanowanej transakcji na otwartym rynku dokonanej przez Timothy P Clackson. Nieplanowane transakcje to transakcje, które nie zostały dokonane w ramach planu handlowego 10b5-1. Notowania akcji przedstawiono na wykresie jako skumulowaną procentową zmianę ceny akcji. Na przykład, jeśli 1 stycznia 2019 r. dokonano transakcji poufnej, wykres pokaże dzienną procentową zmianę papieru wartościowego do dnia dzisiejszego. Jeżeli cena akcji wzrosłaby w tym czasie z 10 do 15 dolarów, skumulowana procentowa zmiana ceny akcji wyniosłaby 50%. Zmiana ceny z 10$ na 20$ będzie wynosić 100%, a zmiana ceny z 10$ na 5$ będzie wynosić -50%.
Ostatecznie staramy się określić, jak blisko transakcje insiderów korelują z nadmiernymi zwrotami (dodatnimi lub ujemnymi) z ceny akcji, aby sprawdzić, czy insider dostosowuje swoje transakcje w taki sposób, aby czerpać korzyści z informacji poufnych. Rozważmy sytuację, w której zrobił to ktoś z wewnątrz. W tej sytuacji oczekiwalibyśmy albo (a) dodatnich zwrotów po zakupach, albo (b) ujemnych zwrotów po sprzedaży. W przypadku (a) wykres ZAKUPU pokazywałby serię krzywych nachylonych w górę, wskazujących dodatnie zwroty po każdej transakcji zakupu. W przypadku (b) wykres SPRZEDAŻ pokazywałby serię krzywych o nachyleniu w dół, wskazujących ujemne zwroty po każdej transakcji sprzedaży.
Samo to jednak nie wystarczy, aby wyciągnąć wnioski. Gdyby np. cena akcji spółki przez wiele lat rosła niecyklicznie, to spodziewalibyśmy się, że wszystkie wykresy po zakupie będą wykazywały tendencję wzrostową. Podobnie niecykliczne spadki na przestrzeni wielu lat spowodowałyby spadek linii na wykresie po transakcjach. Żaden z tych wykresów nie sugeruje wykorzystywania informacji poufnych.
Najsilniejszym wskaźnikiem byłaby sytuacja, gdy cena akcji miała charakter wyjątkowo cykliczny, a na wykresie KUPNO występowały zarówno pozytywne sygnały na wykresie KUPNA, jak i negatywne na wykresie SPRZEDAŻY. Sytuacja ta wysoce sugerowałaby osobę mającą dostęp do informacji poufnych, która wykorzystywała transakcje w celu uzyskania korzyści finansowej.
Zakupy insidera XLO / Xilio Therapeutics, Inc. – krótkoterminowa analiza zysków
W tej części analizujemy rentowność każdego nieplanowanego zakupu od poufnych informacji na otwartym rynku dokonanego w XLO / Xilio Therapeutics, Inc.. Analiza ta pomaga zrozumieć, czy insider konsekwentnie generuje nietypowe zyski i czy warto ją śledzić. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .
Poniższa tabela przedstawia najnowsze zakupy na otwartym rynku, które nie były częścią planu handlu automatycznego.
| Data transakcji | Ticker | Insider | Zgłoszone Akcje |
Zgłoszona Cena |
Skorygowane Akcje |
Skorygowana Cena |
Podstawa kalkulacji kosztów | Dni do maks |
Cena maks |
Maks Zysk ($) |
Maksymalny zwrot (%) |
|---|---|---|---|---|---|---|---|
| Nie znane są żadne nieplanowane transakcje na otwarttm rynku dla tej kombinacji insidera i papieru wartościowego |
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Sprzedaż insidera XLO / Xilio Therapeutics, Inc. — analiza strat krótkoterminowych
W tej sekcji analizujemy możliwość uniknięcia krótkoterminowych strat w wyniku każdej nieplanowanej sprzedaży poufnych informacji na otwartym rynku dokonanej w XLO / Xilio Therapeutics, Inc.. Konsekwentny wzorzec unikania strat może sugerować, że przyszłe transakcje sprzedaży mogą przewidywać spadki cen. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .
Poniższa tabela przedstawia najnowsze sprzedaże na otwartym rynku, które nie były częścią planu handlu automatycznego.
| Data transakcji | Ticker | Insider | Zgłoszone Akcje |
Zgłoszona Cena |
Skorygowane Akcje |
Skorygowana Cena |
Podstawa kalkulacji kosztów | Dni do min |
Cena min |
Uniknięta maksymalna strata ($) |
Uniknięta Maksymalna strata (%) |
|---|---|---|---|---|---|---|---|
| Nie znane są żadne nieplanowane transakcje na otwarttm rynku dla tej kombinacji insidera i papieru wartościowego |
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Historia handlu insiderów
Ta tabela przedstawia pełną listę transakcji insiderów dokonanych przez firmę Timothy P Clackson ujawnioną Komisji Papierów Wartościowych (SEC).
| Data pliku | Data trans | Formularz | Ticker | Bezpieczeństwo | Kod | Akcje | Pozostałe akcje | Zmiana procent |
Cena udziału |
Wartość trans |
Pozostała Wartość |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-24 |
|
4 | ELEV |
Elevation Oncology, Inc.
Common Stock |
U - Other | -47 330 | 0 | -100,00 | 0,36 | -17 039 | ||
| 2023-09-05 |
|
4 | ELEV |
Elevation Oncology, Inc.
Common Stock |
G - Gift | -15 777 | 0 | -100,00 | ||||
| 2022-11-14 |
|
4 | THRX |
Theseus Pharmaceuticals, Inc.
Common Stock |
P - Purchase | 2 500 | 351 030 | 0,72 | 6,80 | 16 995 | 2 386 302 | |
| 2022-10-14 |
|
4 | FMTX |
Forma Therapeutics Holdings, Inc.
Common Stock |
U - Other | -7 250 | 0 | -100,00 | ||||
| 2022-10-14 |
|
4 | FMTX |
Forma Therapeutics Holdings, Inc.
Common Stock |
U - Other | -23 590 | 0 | -100,00 | ||||
| 2022-06-22 |
|
4 | ELEV |
Elevation Oncology, Inc.
Common Stock |
G - Gift | -31 553 | 15 777 | -66,67 | ||||
| 2022-06-09 |
|
4 | FMTX |
Forma Therapeutics Holdings, Inc.
Common Stock |
A - Award | 4 500 | 30 840 | 17,08 | ||||
| 2022-02-23 |
|
4 | THRX |
Theseus Pharmaceuticals, Inc.
Stock Option (right to buy) |
A - Award | 450 000 | 450 000 | |||||
| 2021-12-22 |
|
4 | THRX |
Theseus Pharmaceuticals, Inc.
Common Stock |
P - Purchase | 2 600 | 348 530 | 0,75 | 9,76 | 25 381 | 3 402 385 | |
| 2021-10-21 | 3 | XLO |
Xilio Therapeutics, Inc.
Common Stock |
20 068 | ||||||||
| 2021-10-21 | 3 | XLO |
Xilio Therapeutics, Inc.
Common Stock |
70 888 | ||||||||
| 2021-10-06 | 3 | THRX |
Theseus Pharmaceuticals, Inc.
Common Stock |
345 930 | ||||||||
| 2021-06-24 | 3 | ELEV |
Elevation Oncology, Inc.
Common Stock |
47 330 | ||||||||
| 2021-06-21 |
|
4 | FMTX |
Forma Therapeutics Holdings, Inc.
Stock Option (Right to Buy) |
A - Award | 8 375 | 8 375 | |||||
| 2021-06-21 |
|
4 | FMTX |
Forma Therapeutics Holdings, Inc.
Common Stock |
A - Award | 2 750 | 26 340 | 11,66 | ||||
| 2020-10-01 |
|
4 | SBPH |
Spring Bank Pharmaceuticals, Inc.
Common Stock |
A - Award | 9 422 | 50 486 | 22,94 | ||||
| 2020-07-01 |
|
4 | SBPH |
Spring Bank Pharmaceuticals, Inc.
Common Stock |
A - Award | 8 588 | 41 064 | 26,44 | ||||
| 2020-06-25 |
|
4 | SBPH |
Spring Bank Pharmaceuticals, Inc.
Stock Option (right to buy) |
A - Award | 7 500 | 7 500 | |||||
| 2020-06-24 |
|
4 | FMTX |
Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock |
S - Sale | -35 067 | 0 | -100,00 | ||||
| 2020-06-24 |
|
4 | FMTX |
Forma Therapeutics Holdings, Inc.,
Common Stock |
P - Purchase | 23 590 | 23 590 | |||||
| 2020-06-22 |
|
4 | FMTX |
Forma Therapeutics Holdings, Inc.,
Stock Option (Right to Buy) |
A - Award | 17 533 | 0 | -100,00 | ||||
| 2020-06-18 | 3 | FMTX |
Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock |
43 144 | ||||||||
| 2020-06-18 | 3 | FMTX |
Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock |
43 144 | ||||||||
| 2020-06-18 | 3 | FMTX |
Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock |
43 144 | ||||||||
| 2020-04-01 |
|
4 | SBPH |
Spring Bank Pharmaceuticals, Inc.
Common Stock |
A - Award | 13 575 | 32 476 | 71,82 | ||||
| 2020-01-02 |
|
4 | SBPH |
Spring Bank Pharmaceuticals, Inc.
Common Stock |
A - Award | 7 991 | 18 901 | 73,24 | ||||
| 2019-10-01 |
|
4 | SBPH |
Spring Bank Pharmaceuticals, Inc.
Common Stock |
A - Award | 3 670 | 10 910 | 50,69 | ||||
| 2019-07-11 |
|
4 | SBPH |
Spring Bank Pharmaceuticals, Inc.
Stock Option (right to buy) |
A - Award | 7 500 | 7 500 | |||||
| 2019-07-01 |
|
4 | SBPH |
Spring Bank Pharmaceuticals, Inc.
Common Stock |
A - Award | 3 421 | 7 240 | 89,58 | ||||
| 2019-04-02 |
|
4 | SBPH |
Spring Bank Pharmaceuticals, Inc.
Common Stock |
A - Award | 1 204 | 3 819 | 46,04 | ||||
| 2019-01-03 |
|
4 | SBPH |
Spring Bank Pharmaceuticals, Inc.
Common Stock |
A - Award | 1 083 | 2 615 | 70,69 | ||||
| 2018-10-02 |
|
4 | SBPH |
Spring Bank Pharmaceuticals, Inc.
Common Stock |
A - Award | 788 | 1 532 | 105,91 | ||||
| 2018-07-03 |
|
4 | SBPH |
Spring Bank Pharmaceuticals, Inc.
Common Stock |
A - Award | 744 | 744 | |||||
| 2018-03-05 |
|
4 | SBPH |
Spring Bank Pharmaceuticals, Inc.
Stock Option (right to buy) |
A - Award | 11 000 | 11 000 | |||||
| 2018-03-05 | 3 | SBPH |
Spring Bank Pharmaceuticals, Inc.
No securities are beneficially owned |
0 | ||||||||
| 2017-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
D - Sale to Issuer | -14 550 | 0 | -100,00 | ||||
| 2017-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
D - Sale to Issuer | -72 980 | 0 | -100,00 | ||||
| 2017-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | -87 125 | 0 | -100,00 | ||||
| 2017-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | -65 000 | 0 | -100,00 | ||||
| 2017-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | -82 000 | 0 | -100,00 | ||||
| 2017-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | -577 | 0 | -100,00 | ||||
| 2017-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | -219 867 | 0 | -100,00 | ||||
| 2017-02-07 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 14 550 | 14 550 | |||||
| 2017-02-02 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -29 333 | 0 | -100,00 | ||||
| 2017-02-02 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
F - Taxes | -9 610 | 219 867 | -4,19 | 23,82 | -228 886 | 5 236 682 | |
| 2017-02-02 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 29 333 | 229 477 | 14,66 | ||||
| 2016-10-25 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -19 638 | 197 884 | -9,03 | 9,56 | -187 739 | 1 891 771 |
| 2016-09-28 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -8 750 | 217 522 | -3,87 | 13,98 | -122 311 | 3 040 610 |
| 2016-09-28 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Performance stock unit |
M - Exercise | -17 500 | 0 | -100,00 | ||||
| 2016-09-28 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 17 500 | 226 272 | 8,38 | ||||
| 2016-09-23 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -20 000 | 208 772 | -8,74 | 13,43 | -268 536 | 2 803 140 |
| 2016-09-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | -59 369 | 0 | -100,00 | ||||
| 2016-09-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -59 369 | 228 772 | -20,60 | 11,73 | -696 398 | 2 683 496 |
| 2016-09-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 59 369 | 288 141 | 25,95 | 7,82 | 464 266 | 2 253 263 |
| 2016-08-23 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -19 436 | 228 772 | -7,83 | 10,47 | -203 538 | 2 395 746 |
| 2016-08-15 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | -25 000 | 0 | -100,00 | ||||
| 2016-08-15 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -25 000 | 248 208 | -9,15 | 10,50 | -262 500 | 2 606 184 |
| 2016-08-15 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 25 000 | 273 208 | 10,07 | 7,69 | 192 250 | 2 100 970 |
| 2016-07-25 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -18 286 | 248 208 | -6,86 | 8,11 | -148 230 | 2 012 024 |
| 2016-07-05 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | -30 000 | 0 | -100,00 | 3,25 | -97 500 | ||
| 2016-07-05 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | -31 422 | 0 | -100,00 | 4,49 | -141 085 | ||
| 2016-07-05 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -30 000 | 266 494 | -10,12 | 7,48 | -224 481 | 1 994 095 |
| 2016-07-05 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 30 000 | 296 494 | 11,26 | 3,25 | 97 500 | 963 606 |
| 2016-07-05 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -31 422 | 266 494 | -10,55 | 7,48 | -235 153 | 1 994 361 |
| 2016-07-05 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 31 422 | 297 916 | 11,79 | 4,49 | 141 085 | 1 337 643 |
| 2016-06-23 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -23 999 | 264 742 | -8,31 | 7,28 | -174 638 | 1 926 501 |
| 2016-05-25 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -17 762 | 288 741 | -5,80 | 8,08 | -143 430 | 2 331 612 |
| 2016-05-02 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -11 700 | 306 503 | -3,68 | 7,13 | -83 478 | 2 186 868 |
| 2016-05-02 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -23 400 | 0 | -100,00 | ||||
| 2016-05-02 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 23 400 | 318 203 | 7,94 | ||||
| 2016-04-25 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -21 409 | 294 803 | -6,77 | 7,37 | -157 864 | 2 173 789 |
| 2016-03-23 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -23 834 | 316 212 | -7,01 | 6,58 | -156 871 | 2 081 244 |
| 2016-03-22 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -10 833 | 0 | -100,00 | ||||
| 2016-03-22 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -5 417 | 340 046 | -1,57 | 6,47 | -35 039 | 2 199 520 |
| 2016-03-22 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 10 833 | 345 463 | 3,24 | ||||
| 2016-03-09 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 26 180 | 26 180 | |||||
| 2016-03-09 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
A - Award | 87 125 | 87 125 | |||||
| 2016-03-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -9 625 | 334 630 | -2,80 | 6,12 | -58 867 | 2 046 631 |
| 2016-03-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | -25 047 | 344 255 | -6,78 | 6,00 | -150 282 | 2 065 530 | |
| 2016-03-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Performance stock unit |
A - Award | 38 500 | 38 500 | |||||
| 2016-03-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Performance stock unit |
M - Exercise | -19 250 | 19 250 | -50,00 | ||||
| 2016-03-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 19 250 | 369 302 | 5,50 | ||||
| 2016-02-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -29 333 | 29 333 | -50,00 | ||||
| 2016-02-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -14 667 | 350 052 | -4,02 | 4,81 | -70 517 | 1 683 015 |
| 2016-02-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 29 333 | 364 719 | 8,75 | ||||
| 2015-09-28 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -8 750 | 334 086 | -2,55 | 6,46 | -56 560 | 2 159 532 |
| 2015-09-28 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Performance stock unit |
A - Award | 35 000 | 35 000 | |||||
| 2015-09-28 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Performance stock unit |
M - Exercise | -17 500 | 17 500 | -50,00 | ||||
| 2015-09-28 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 17 500 | 342 836 | 5,38 | ||||
| 2015-07-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -7 000 | 325 336 | -2,11 | 8,54 | -59 797 | 2 779 150 |
| 2015-07-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Performance stock unit |
M - Exercise | -14 000 | 0 | -100,00 | ||||
| 2015-07-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 14 000 | 332 336 | 4,40 | ||||
| 2015-04-30 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 70 200 | 70 200 | |||||
| 2015-04-27 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -123 766 | 316 548 | -28,11 | 9,50 | -1 175 777 | 3 007 206 |
| 2015-03-23 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -13 333 | 0 | -100,00 | ||||
| 2015-03-23 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -6 667 | 440 314 | -1,49 | 8,55 | -57 016 | 3 765 565 |
| 2015-03-23 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 13 333 | 446 981 | 3,07 | ||||
| 2015-03-23 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -5 417 | 433 648 | -1,23 | 8,84 | -47 910 | 3 835 313 |
| 2015-03-23 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | -20 657 | 0 | -100,00 | ||||
| 2015-03-23 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -10 833 | 10 833 | -50,00 | ||||
| 2015-03-23 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | -20 657 | 440 314 | -4,48 | 9,00 | -185 913 | 3 962 826 | |
| 2015-03-23 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 20 657 | 460 971 | 4,69 | 7,56 | 156 167 | 3 484 941 | |
| 2015-03-23 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 10 833 | 439 065 | 2,53 | ||||
| 2015-02-24 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | -24 036 | 31 422 | -43,34 | ||||
| 2015-02-24 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | -24 999 | 0 | -100,00 | ||||
| 2015-02-24 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -24 036 | 428 232 | -5,31 | 8,00 | -192 288 | 3 425 856 |
| 2015-02-24 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 24 036 | 452 268 | 5,61 | 4,49 | 107 922 | 2 030 683 | |
| 2015-02-24 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -24 999 | 428 232 | -5,52 | 8,00 | -199 992 | 3 425 856 |
| 2015-02-24 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 24 999 | 453 231 | 5,84 | 2,62 | 65 497 | 1 187 465 | |
| 2015-02-04 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -29 334 | 58 666 | -33,33 | ||||
| 2015-02-04 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -14 667 | 428 232 | -3,31 | 6,33 | -92 820 | 2 710 066 |
| 2015-02-04 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 29 334 | 442 899 | 7,09 | ||||
| 2014-07-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Performance stock unit |
M - Exercise | -14 000 | 14 000 | -50,00 | ||||
| 2014-07-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
F - Taxes | -4 564 | 413 565 | -1,09 | 5,57 | -25 421 | 2 303 557 | |
| 2014-07-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 14 000 | 418 129 | 3,46 | ||||
| 2014-04-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -6 500 | 403 028 | -1,59 | 8,21 | -53 337 | 3 307 127 |
| 2014-04-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -13 000 | 0 | -100,00 | ||||
| 2014-04-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 13 000 | 409 528 | 3,28 | ||||
| 2014-03-21 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -6 667 | 394 377 | -1,66 | 7,89 | -52 583 | 3 110 451 |
| 2014-03-21 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -13 333 | 13 333 | -50,00 | ||||
| 2014-03-21 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 13 333 | 401 044 | 3,44 | ||||
| 2014-03-21 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -10 834 | 21 666 | -33,34 | ||||
| 2014-03-21 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
F - Taxes | -3 442 | 387 711 | -0,88 | 8,19 | -28 190 | 3 175 353 | |
| 2014-03-21 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 10 834 | 391 153 | 2,85 | ||||
| 2014-02-04 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 88 000 | 88 000 | |||||
| 2013-12-20 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -9 750 | 380 319 | -2,50 | 5,14 | -50 115 | 1 954 840 |
| 2013-12-20 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 19 500 | 390 069 | 5,26 | ||||
| 2013-09-10 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -8 449 | 370 451 | -2,23 | 22,00 | -185 878 | 8 149 922 |
| 2013-07-18 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -14 000 | 378 900 | -3,56 | 19,79 | -277 045 | 7 498 014 |
| 2013-07-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Performance stock unit |
M - Exercise | -28 000 | 28 000 | -50,00 | ||||
| 2013-07-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Performance stock unit |
A - Award | 56 000 | 56 000 | |||||
| 2013-07-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 28 000 | 392 900 | 7,67 | ||||
| 2013-04-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | -6 500 | 363 705 | -1,76 | 18,04 | -117 245 | 6 560 402 | |
| 2013-04-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -13 000 | 0 | -100,00 | ||||
| 2013-04-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 13 000 | 370 205 | 3,64 | ||||
| 2013-03-26 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | -19 167 | 357 205 | -5,09 | 18,87 | -361 766 | 6 742 030 | |
| 2013-03-26 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -38 333 | 0 | -100,00 | ||||
| 2013-03-26 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 38 333 | 376 372 | 11,34 | ||||
| 2013-03-22 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | -6 667 | 338 039 | -1,93 | 19,46 | -129 718 | 6 577 123 | |
| 2013-03-22 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -13 334 | 0 | -100,00 | ||||
| 2013-03-22 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 13 334 | 344 706 | 4,02 | ||||
| 2013-03-20 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
A - Award | 65 000 | 65 000 | |||||
| 2013-03-20 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 32 500 | 32 500 | |||||
| 2013-03-05 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -9 838 | 331 372 | -2,88 | 21,00 | -206 598 | 6 958 812 |
| 2013-01-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | -8 631 | 17 262 | -33,33 | ||||
| 2013-01-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | -44 542 | 0 | -100,00 | ||||
| 2013-01-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | -4 766 | 0 | -100,00 | ||||
| 2013-01-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 8 631 | 341 210 | 2,60 | 7,82 | 67 494 | 2 668 262 | |
| 2013-01-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 44 542 | 332 579 | 15,46 | 4,49 | 199 994 | 1 493 280 | |
| 2013-01-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 766 | 288 037 | 1,68 | 5,23 | 24 926 | 1 506 434 | |
| 2012-12-21 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | -27 000 | 4 766 | -85,00 | ||||
| 2012-12-21 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 27 000 | 282 940 | 10,55 | 5,23 | 141 210 | 1 479 776 | |
| 2012-12-20 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
F - Taxes | -8 142 | 255 940 | -3,08 | 20,18 | -164 306 | 5 164 869 | |
| 2012-12-20 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 19 500 | 264 082 | 7,97 | ||||
| 2012-09-04 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | -1 | 24 999 | 0,00 | ||||
| 2012-09-04 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | -10 000 | 30 000 | -25,00 | ||||
| 2012-09-04 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 | 244 170 | 0,00 | 2,62 | 3 | 639 725 | |
| 2012-09-04 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 10 000 | 244 169 | 4,27 | 3,25 | 32 500 | 793 549 | |
| 2012-08-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | -36 843 | 0 | -100,00 | ||||
| 2012-08-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -36 843 | 234 169 | -13,59 | 20,00 | -736 860 | 4 683 380 |
| 2012-08-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 36 843 | 271 012 | 15,73 | 7,56 | 278 533 | 2 048 851 | |
| 2012-08-01 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | -23 234 | 31 766 | -42,24 | ||||
| 2012-08-01 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -23 234 | 234 169 | -9,03 | 19,00 | -441 446 | 4 449 211 |
| 2012-08-01 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 23 234 | 257 403 | 9,92 | 5,23 | 121 514 | 1 346 218 | |
| 2012-05-04 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | -20 000 | 0 | -100,00 | ||||
| 2012-05-04 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -20 000 | 233 778 | -7,88 | 17,00 | -340 000 | 3 974 226 |
| 2012-05-04 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 20 000 | 253 778 | 8,56 | 7,44 | 148 800 | 1 888 108 | |
| 2012-04-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -7 111 | 233 778 | -2,95 | 15,00 | -106 665 | 3 506 670 |
| 2012-04-17 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -31 600 | 240 889 | -11,60 | 14,83 | -468 628 | 3 572 384 |
| 2012-04-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -5 200 | 272 489 | -1,87 | 16,18 | -84 134 | 4 408 763 |
| 2012-04-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -13 000 | 26 000 | -33,33 | ||||
| 2012-04-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 13 000 | 277 689 | 4,91 | ||||
| 2012-04-03 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -26 061 | 264 689 | -8,96 | 16,34 | -425 876 | 4 325 415 |
| 2012-03-28 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | -7 500 | 0 | -100,00 | ||||
| 2012-03-28 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -7 500 | 290 750 | -2,51 | 16,00 | -120 000 | 4 652 000 |
| 2012-03-28 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 500 | 298 250 | 2,58 | 6,39 | 47 925 | 1 905 818 | |
| 2012-03-26 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -15 333 | 290 750 | -5,01 | 15,41 | -236 211 | 4 479 120 |
| 2012-03-26 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | -38 333 | 38 333 | -50,00 | ||||
| 2012-03-26 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 38 333 | 306 083 | 14,32 | ||||
| 2012-03-21 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 40 000 | 40 000 | |||||
| 2012-03-21 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
A - Award | 82 000 | 82 000 | |||||
| 2012-03-21 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | -36 400 | 267 750 | -11,97 | 15,02 | -546 622 | 4 020 829 | |
| 2012-03-21 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | 91 000 | 0 | -100,00 | ||||
| 2012-03-21 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | -91 000 | 304 150 | -23,03 | ||||
| 2012-03-19 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | -8 449 | 0 | -100,00 | ||||
| 2012-03-19 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | -6 615 | 0 | -100,00 | ||||
| 2012-03-19 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 8 449 | 213 150 | 4,13 | 4,19 | 35 401 | 893 098 | |
| 2012-03-19 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 615 | 204 701 | 3,34 | 4,05 | 26 791 | 829 039 | |
| 2012-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | -16 500 | 16 500 | -50,00 | ||||
| 2012-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | -41 551 | 8 449 | -83,10 | ||||
| 2012-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy) |
M - Exercise | -18 385 | 6 615 | -73,54 | ||||
| 2012-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -76 436 | 119 882 | -38,93 | 15,12 | -1 155 781 | 1 812 724 |
| 2012-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 16 500 | 196 318 | 9,18 | 3,90 | 64 350 | 765 640 | |
| 2012-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 41 551 | 179 818 | 30,05 | 4,19 | 174 099 | 753 437 | |
| 2012-02-16 |
|
4 | ARIA |
ARIAD PHARMACEUTICALS INC
Common Stock |
M - Exercise | 18 385 | 138 267 | 15,34 | 4,05 | 74 459 | 559 981 |
